Analgesic Efficacy of Combined PECS II and PIP Block Versus Thoracic Paravertebral Block Post-Mastectomy

Official record

Identifier

NCT07738770

Recruiting locations

country

Indonesia

Interventions studied

Combined PECS II and Superficial PIP BlockThoracic paravertebral block (TPVB)

Lead sponsor

Dharmais National Cancer Center Hospital

Target enrolment

72 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Recruiting

First posted

Jul 31, 2026

Last updated on the registry

Jul 31, 2026

Age

18 Years – 60 Years

Sex

FEMALE

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. Female patients aged 18 to 60 years.
2. Scheduled for breast cancer surgery (mastectomy with or without axillary lymph node dissection \[ALND\]).
3. American Society of Anesthesiologists (ASA) physical status I to III.
4. Provided signed written informed consent to participate in the study.

Exclusion Criteria:

1. Patient refusal to participate in the study.
2. Known allergy to local anesthetics or study medications (e.g., bupivacaine, ketorolac, morphine).
3. Coagulation disorders or coagulopathy.
4. Mastectomy procedure with immediate breast reconstruction.
5. Pre-existing chronic cancer pain with active usage of strong opioids (e.g., morphine, fentanyl).
6. Cognitive impairment or inability to comprehend the pain assessment scale (NRS).
7. Pregnancy.
8. Active infection at the planned regional block injection site.